We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Medlab Middle East 2024 Provides a Peek into the Laboratory of the Future

By LabMedica International staff writers
Posted on 05 Feb 2024
Print article
Image: Medlab Middle East 2024 has seen a 20% increase in exhibitors (Photo courtesy of Informa Markets)
Image: Medlab Middle East 2024 has seen a 20% increase in exhibitors (Photo courtesy of Informa Markets)

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets, has returned to the Dubai World Trade Centre. Now in its 23rd year, Medlab Middle East features 900 exhibitors from more than 40 countries, up 20% from last year, and is being attended by more than 30,000 attendees. As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in developing the value of laboratory medicine in reshaping the future of diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers, and distributors, to share best practice, showcase innovations, collaborate and network.

Medlab Middle East 2024 is exhibiting eight specialized product categories which include disposables, healthcare/general services, imaging, infrastructure, IT, laboratory, medical equipment and pharma/nutrition. Attendees can explore the latest laboratory technologies from every corner of the globe with dedicated country pavilions from China, Taiwan, Brazil, Finland, Poland, the USA, Spain, Korea, Italy, Egypt, and the UK. A key highlight of the 2024 edition of Medlab Middle East, taking place from 5-8 February, is the newly introduced ‘NextGen Medicine Zone and Conference, which is hosted in partnership with Express Med Diagnostics and Research (Manama, Bahrain). This innovative exhibition zone showcases over 100 exhibitors and brings into focus a pioneering area in the medical laboratory field that aims to customize healthcare to individuals, using advanced technologies and new developments in medical science.

The NextGen Medicine Conference, taking place from 5 to 6 February, explores topics such as early cancer detection, precision oncology, preventative health screening, longevity, developments in cancer genetics and oncogenomics as well as updates on Middle East genome projects. The conference also explores the digitalization aspects of NextGen Medicine which includes Artificial Intelligence (AI), bioinformatics, and the cybersecurity of data. Attendees can stay up to date with the latest insights and innovations in NextGen Medicine at expert-led industry workshops running from 5-7 February. Medlab Middle East Congress, the region’s only multi-disciplinary congress, has returned for another year. Offering 12 CME-accredited live in-person conferences throughout the four-day exhibition, the congress features over 130 speakers and 150 sessions, with over 4,000 delegates expected. NextGen Medicine and Clinical Genomic Interpretation are new additions to the Medlab Middle East congress this year, with returning tracks including Laboratory Management, Lab Quality Management, Clinical Chemistry, Immunology, Hematology, Clinical Microbiology, Blood Transfusion Medicine, Histopathology, Future of Lab and Sustainability in the Lab.

Additionally, innovation takes center stage at Labpreneur, Medlab Middle East’s annual start-up competition. Held on the last day of the exhibition, Labpreneur features 10 shortlisted start-ups that have created revolutionary concepts for the medical laboratory field. The winner of the competition is set to receive complimentary stand space for Medlab Middle East 2025 along with a prestigious award. Fostering the talents of future scientists, Medlab Middle East is hosting the second edition of LabQ, an inter-college quiz competition on pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. The Scientific Poster Competition is returning this year, with the winner receiving a research grant of a value of up to USD 3,000. Elsewhere, attendees can expand their knowledge of the medical laboratory industry at the Medlab Partners Forum, which includes a think tank session from global research firm Frost & Sullivan and an insightful presentation from The Royal College of Pathologists on ‘The Global Challenge of Antimicrobial Resistance’.

“Medlab Middle East provides a unique platform for the laboratory industry to showcase innovative products, state-of-the-art services, and cutting-edge solutions in a central global hub,” said Tom Coleman, Exhibition Director for Informa Markets. “One of the most exciting features of this year's exhibition is the NextGen Medicine Zone and Conference, which promises to be a game-changer in the field. This groundbreaking zone will bring together experts from around the world who will share the latest scientific advancements, providing a unique opportunity for industry professionals to learn and explore new possibilities.”

Related Links:
Informa Markets
Express Med Diagnostics and Research

New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Epstein-Barr Virus Test
ReQuest EB VCA IgM ELISA Kit
New
Silver Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Microbiology

view channel
Image: The QIAstat-Dx mini gastrointestinal panel has secured U.S. clearance to support year-round outpatient care (Photo courtesy of QIAGEN)

Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions

Acute infectious gastroenteritis is a major cause of outpatient visits and hospitalizations in the U.S., with over 179 million cases estimated annually. Now, a new gastrointestinal panel designed to provide... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.